423 related articles for article (PubMed ID: 19188160)
1. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
[TBL] [Abstract][Full Text] [Related]
3. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects.
Yin Y; Ni J; Chen M; Guo Y; Yeh S
Clin Cancer Res; 2009 Jan; 15(1):190-200. PubMed ID: 19118046
[TBL] [Abstract][Full Text] [Related]
4. Alpha-vitamin E derivative, RRR-alpha-tocopheryloxybutyric acid inhibits the proliferation of prostate cancer cells.
Chang E; Ni J; Yin Y; Lin CC; Chang P; James NS; Chemler SR; Yeh S
Asian J Androl; 2007 Jan; 9(1):31-9. PubMed ID: 17187157
[TBL] [Abstract][Full Text] [Related]
5. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA.
Anderson K; Simmons-Menchaca M; Lawson KA; Atkinson J; Sanders BG; Kline K
Cancer Res; 2004 Jun; 64(12):4263-9. PubMed ID: 15205340
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
7. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
8. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis.
Lawson KA; Anderson K; Snyder RM; Simmons-Menchaca M; Atkinson J; Sun LZ; Bandyopadhyay A; Knight V; Gilbert BE; Sanders BG; Kline K
Cancer Chemother Pharmacol; 2004 Nov; 54(5):421-31. PubMed ID: 15197487
[TBL] [Abstract][Full Text] [Related]
9. RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness.
Zhang M; Altuwaijri S; Yeh S
Oncogene; 2004 Apr; 23(17):3080-8. PubMed ID: 15048090
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E succinate promotes breast cancer tumor dormancy.
Malafa MP; Neitzel LT
J Surg Res; 2000 Sep; 93(1):163-70. PubMed ID: 10945959
[TBL] [Abstract][Full Text] [Related]
13. Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells.
Ni J; Pang ST; Yeh S
Prostate; 2007 Apr; 67(5):463-71. PubMed ID: 17252538
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
Dorai T; Cao YC; Dorai B; Buttyan R; Katz AE
Prostate; 2001 Jun; 47(4):293-303. PubMed ID: 11398177
[TBL] [Abstract][Full Text] [Related]
15. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction.
Xiao D; Lew KL; Kim YA; Zeng Y; Hahm ER; Dhir R; Singh SV
Clin Cancer Res; 2006 Nov; 12(22):6836-43. PubMed ID: 17121905
[TBL] [Abstract][Full Text] [Related]
16. Preclinical antitumor activity of the oral platinum analog satraplatin.
Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E succinate decreases lung cancer tumor growth in mice.
Quin J; Engle D; Litwiller A; Peralta E; Grasch A; Boley T; Hazelrigg S
J Surg Res; 2005 Aug; 127(2):139-43. PubMed ID: 16083751
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention.
Crispen PL; Uzzo RG; Golovine K; Makhov P; Pollack A; Horwitz EM; Greenberg RE; Kolenko VM
Prostate; 2007 May; 67(6):582-90. PubMed ID: 17262802
[TBL] [Abstract][Full Text] [Related]
19. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
[TBL] [Abstract][Full Text] [Related]
20. Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer.
Hahn T; Szabo L; Gold M; Ramanathapuram L; Hurley LH; Akporiaye ET
Cancer Res; 2006 Oct; 66(19):9374-8. PubMed ID: 17018590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
